Xuanming Yang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
IL-12 augments adoptive cell therapy by reshaping CD8+ T dynamics and broadening antitumor immunity.
IL-12 augments adoptive cell therapy by reshaping CD8+ T dynamics and broadening antitumor immunity.
Journal: Cancer letters
Published: December 17, 2025
OX40-heparan sulfate binding facilitates CAR T cell penetration into solid tumors in mice.
Journal: Science translational medicine
Published: June 18, 2025
BCL-2 mutant B7H6-CAR-T cells synergized with venetoclax for treating small cell lung cancer.
Journal: Journal for immunotherapy of cancer
Published: April 18, 2025
A novel antagonist of the CCL5/CCR5 axis suppresses the tumor growth and metastasis of triple-negative breast cancer by CCR5-YAP1 regulation.
Journal: Cancer letters
Published: June 27, 2023
Dysregulation of Wnt/β-catenin signaling contributes to intestinal inflammation through regulation of group 3 innate lymphoid cells.
Journal: Nature communications
Published: June 14, 2023
A spike-targeting bispecific T cell engager strategy provides dual layer protection against SARS-CoV-2 infection in vivo.
Journal: Communications biology
Published: February 21, 2023
Editorial: Development and Potential Mechanisms of Low Molecular Weight Drugs for Cancer Immunotherapy.
Journal: Frontiers in immunology
Published: April 14, 2022
Type I Interferon Promotes Antitumor T Cell Response in CRPC by Regulating MDSC.
Journal: Cancers
Published: August 23, 2021
A CLDN18.2-Targeting Bispecific T Cell Co-Stimulatory Activator for Cancer Immunotherapy.
Journal: Cancer management and research
Published: July 27, 2021
T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies.
Journal: Nature communications
Published: June 09, 2021
Last Updated: 09/26/2026